Neurocrine Biosciences, a mid cap pharmaceutical firm is up for earnings on February 7th.
Investor and trader interest seems to be moderately increasing in the past week. The combined
MACD / RSI indicator is bullish. This looks good for a longtrade to be taken in the premarket
before 7:45 AM as earnings report at 8:00
NBIX Stock Breaks All-Time Highs: A Strong Buy Opportunity Emerges
Neurocrine Biosciences Inc. (NBIX) is currently making waves in the stock market as it breaks out of its all-time highs, signaling a promising opportunity for investors. After 14 years of steady upward momentum and price consolidation, NBIX appears poised for further growth, with technical...
Neurocrine Biosciences (NBIX), a biotech company specializing in treatments for neurological, endocrine, and psychiatric disorders, is poised for opportunities in congenital adrenal hyperplasia (CAH). Analysts project NBIX to potentially achieve worldwide revenue of $660 million by fiscal year 2030, emphasizing substantial market potential. Crinecerfont, an NBIX...
Neurocrine Biosciences, Inc.
Intraday - We look to Buy at 104.23 (stop at 98.97)
A sequence of intraday higher highs and lows has been posted. This is positive for sentiment and the uptrend has potential to return. A weaker opening is expected to challenge bullish resolve. Support is located at 104.00 and should stem dips to this area. Dip buying offers good...
NBIX is in the biotech sector which I have been highlighting for several months as one of the strongest areas in the market.
After emerging from a textbook breakout pattern in early August, shares have consolidated in a tight handle formation.
If you look at the relative strength line at the top of the chart, you will notice three pink dots over the last several...
It looks like a beautiful flag (or pennant) to me, with high volume at the pole and the volume drying up during the consolidation.
I am expecting continuation.
NBIX snapped up after hitting a new yearly low and falling below the bands set on an 80 SMA. Price returns to the bands on this setting eventually. When price is over the bands on this setting, then it will usually go down to settle back inside the bands. (orange arrow at top)
Price being below the bands exhibits a lot of selling pressure, but when selling is...
Hey my friends, NEUROCRINE BIOSCIENCES is in a bearish fake movement with a return of traded buy volume and a large hammer candle upside down On TIMEFRAME M1 we see a dash with a large buy volume issued it came test and the highest of the bollinger to go to the top of the stabilization zone and test it. Big potential to breakout the price at the same time the zone...
